Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

N Black, E Stockings, G Campbell, LT Tran… - The Lancet …, 2019 - thelancet.com
Background Medicinal cannabinoids, including medicinal cannabis and pharmaceutical
cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and …

[HTML][HTML] US epidemiology of cannabis use and associated problems

DS Hasin - Neuropsychopharmacology, 2018 - nature.com
This review provides an overview of the changing US epidemiology of cannabis use and
associated problems. Adults and adolescents increasingly view cannabis as harmless, and …

Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States

DS Hasin, AL Sarvet, JL Meyers, TD Saha… - JAMA …, 2018 - jamanetwork.com
Importance No US national data are available on the prevalence and correlates ofDSM-5–
defined major depressive disorder (MDD) or on MDD specifiers as defined inDSM-5 …

Cannabis, cannabinoids, and sleep: a review of the literature

KA Babson, J Sottile, D Morabito - Current psychiatry reports, 2017 - Springer
Cannabis, Cannabinoids, and Sleep: a Review of the Literature | Current Psychiatry Reports
Skip to main content SpringerLink Account Menu Find a journal Publish with us Track your …

The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review

SM Nugent, BJ Morasco, ME O'Neil… - Annals of internal …, 2017 - acpjournals.org
Background: Cannabis is increasingly available for the treatment of chronic pain, yet its
efficacy remains uncertain. Purpose: To review the benefits of plant-based cannabis …

Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis

JD Kosiba, SA Maisto, JW Ditre - Social science & medicine, 2019 - Elsevier
Rationale Certifications for medical cannabis are generally restricted to a small number of
specific medical conditions, yet patients frequently report symptoms of pain, anxiety, and …

[HTML][HTML] Sex-dependent effects of cannabis and cannabinoids: a translational perspective

ZD Cooper, RM Craft - Neuropsychopharmacology, 2018 - nature.com
Recent policy changes have led to significant increases in the use of cannabis for both
medical and recreational purposes. Although men are more likely to endorse past month …

Cannabis and mental illness: a review

DJE Lowe, JD Sasiadek, AS Coles… - European archives of …, 2019 - Springer
With the increasing push to legalize cannabis in Western nations, there is a need to gage
the potential impact of this policy change on vulnerable populations, such as those with …

Cannabis use and risk of prescription opioid use disorder in the United States

M Olfson, MM Wall, SM Liu… - American Journal of …, 2018 - Am Psychiatric Assoc
Objective: The authors sought to determine whether cannabis use is associated with a
change in the risk of incident nonmedical prescription opioid use and opioid use disorder at …

Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients

P Lucas, Z Walsh - International Journal of Drug Policy, 2017 - Elsevier
Abstract Background In 2014 Health Canada replaced the Marihuana for Medical Access
Regulations (MMAR) with the Marihuana for Medical Purposes Regulations (MMPR). One of …